IPC signs MoU with UP Pharma Council to strengthen drug quality
The Indian Pharmacopoeia Commission has signed a memorandum of understanding (MOU) with the Uttar Pradesh Promote Pharma Council to strengthen quality standards, regulatory compliance and innovation in the pharmaceutical and medical device sectors.
The MoU was signed during the YEIDA MedTech Investors Meet and Site Visit 2026 held at India Expo Mart in Greater Noida on July 14.
The partnership aims to promote quality standards, regulatory excellence, innovation and capacity building across the pharmaceutical and medical device ecosystem, the Health Ministry said in a statement.
Under the collaboration, the two organisations will work to strengthen quality standards and regulatory compliance in the pharmaceutical and medical device industries, while promoting awareness of the Indian Pharmacopoeia, pharmacovigilance and materiovigilance.
The partnership also envisages organising joint training programmes, workshops and stakeholder awareness initiatives, besides fostering research, innovation and industry-academia collaborations, the statement said.
The MoU will support micro, small and medium enterprises (MSMEs) by providing digital tools for adverse event reporting and enhance patient safety through quality assurance and post-market surveillance initiatives, the statement said.
It said the collaboration reflects the Commission’s commitment to advancing healthcare quality standards, supporting innovation and strengthening India’s regulatory framework, while contributing to the growth of Uttar Pradesh as a major hub for pharmaceuticals, medical devices and healthcare technologies.
The partnership seeks to build a stronger ecosystem focused on quality, safety, innovation and global competitiveness, it added.
